Proshares Ultra Nasdaq Biotech

BIB
Share your thoughts

What's on your mind?

0 / 2,000
691 followers · 0 opinions
▲Bullish50%
50%Bearish▼
  • C
    Chincheekheong_sEg

    Good

    Novo Nordisk's U.S. stock pre-market fell 11%, while Eli Lilly rose over 4% in pre-market trading. Novo Nordisk's CagriSema performed worse than Eli Lilly's Zepbound in trials